Area:
Neurobiology of Pain and Pain Control
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Andrew J. Mannes is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
1999 |
Mannes, Andrew J |
N01Activity Code Description: Undocumented code - click on the grant title for more information. |
Gene Therapy For Cancer and Arthritic Pain @ University of Pennsylvania
neoplasm /cancer therapy; tissue /cell culture; transfection /expression vector
|
0.904 |
1999 — 2001 |
Mannes, Andrew J |
K08Activity Code Description: To provide the opportunity for promising medical scientists with demonstrated aptitude to develop into independent investigators, or for faculty members to pursue research aspects of categorical areas applicable to the awarding unit, and aid in filling the academic faculty gap in these shortage areas within health profession's institutions of the country. |
Viral Expression of Opioid Receptors For Severe Pain @ University of Pennsylvania
Pain continues to be a primary concern and a major complication in patients suffering from advanced cancer. Despite improvements in medication, delivery systems and physician awareness, a significant population of cancer patients continue to experience severe, intractable pain. Alternative treatment addressing severe pain would substantially reduce the suffering and improve the quality of life of these patients. This study proposes a novel approach to managing severe chronic pain. The hypothesis to be tested is that over-expression of opioid receptors in the dorsal horn of the primary afferents will produce profound analgesia while reducing drug requirements for pain relief. Native opioid receptors will be over-expressed using replication defective adenovirus to confer increased drug sensitivity to the synapse of the primary pain fibers in the spinal cord. Lower doses of drug are needed to obtain effective analgesia, thereby decreasing opioid requirements and systemic untoward effects. The results of this study will demonstrate the feasibility of this approach to pain therapy in rat pain models and provide the basis for future clinical trials. Dr. Mannes, an Assistant Professor of Anesthesiology at the University of Pennsylvania Medical Center, is applying for a Clinical Investigator Award to pursue an academic career focusing on gene therapy to alleviate severe pain. He has a long-standing interest in treating pain including his fellowship in pain management and current clinical experience. This application requests support to allow him to undertake a comprehensive career development program including: 1) further course work in molecular biology, gene therapy, virology, immunology and neuroanatomy; 2) a research preceptorship with Michael Iadarola, Ph.D., extensive consultation with James Wilson, Director of the Institute for Human Gene Therapy, and John Farrar, MD; and 3) a research project that will provide him with the skills and experience to pursue a successful career as an independent investigator.
|
0.904 |